Who Owns Phathom Pharmaceuticals, Inc. (PHAT)?Hedge Fund & Institutional Holders
Institutional Holders
50
as of Q4 2025
Total Institutional Value
$InfinityT
% of Float Held
2.6080263577477217e+292%
QoQ Change in Holders
+5 / -2
Price History
PHAT — Biggest New Institutional Buyers This Quarter
| Fund | Action | Shares Added | Value Added |
|---|---|---|---|
| Invesco Ltd. | Increased | +55K | +$19.5B |
| Divisadero Street Capital Management, LP | New Position | +662K | +$11.0B |
| Catalys Pacific, LLC | Increased | +262K | +$10.0B |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Increased | +395K | +$7.2B |
| NEXT CENTURY GROWTH INVESTORS LLC | New Position | +394K | +$6.5B |
| Simplify Asset Management Inc. | New Position | +322K | +$5.3B |
| SummitTX Capital, L.P. | Increased | +132K | +$4.0B |
| BANK OF AMERICA CORP /DE/ | Increased | +10K | +$4.0B |
| GOLDMAN SACHS GROUP INC | Increased | +240K | +$3.2B |
| D. E. Shaw & Co., Inc. | New Position | +261K | +$3.0B |
| CAXTON ASSOCIATES LLP | Increased | +143K | +$2.5B |
| JPMORGAN CHASE & CO | Increased | +160K | +$2.4B |
| Birchview Capital, LP | Increased | +110K | +$2.2B |
| Hennion & Walsh Asset Management, Inc. | New Position | +115K | +$1.9B |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | Increased | +32K | +$1.7B |
PHAT — Institutions Reducing or Closing Positions
| Fund | Action | Shares Sold | Value Sold |
|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | Decreased | -3.0M | -$25.8B |
| AMERIPRISE FINANCIAL INC | Decreased | -369K | -$3.5B |
| Walleye Capital LLC | Closed Position | -290K | -$3.4B |
| NewEdge Advisors, LLC | Decreased | -700 | -$2.2B |
| CITADEL ADVISORS LLC | Decreased | -197K | -$2.0B |
| ROYAL BANK OF CANADA | Decreased | -140K | -$1.9B |
| Catalio Capital Management, LP | Decreased | -430K | -$1.7B |
| ExodusPoint Capital Management, LP | Decreased | -49K | -$838.9M |
| RHUMBLINE ADVISERS | Decreased | -10K | -$726.4M |
| WELLINGTON MANAGEMENT GROUP LLP | Decreased | -12K | -$723.8M |
| XTX Topco Ltd | Decreased | -15K | -$642.5M |
| BARCLAYS PLC | Decreased | -43K | -$510.7M |
| BALYASNY ASSET MANAGEMENT L.P. | Decreased | -88K | -$474.0M |
| TUDOR INVESTMENT CORP ET AL | Decreased | -6K | -$401.2M |
| PharVision Advisers, LLC | Closed Position | -31K | -$364.5M |
Top Institutional Holders(Q4 2025)
| # | Fund | Shares | Value | % of Portfolio | Type |
|---|---|---|---|---|---|
| 1 | Frazier Life Sciences Management, L.P. | 12,466,489 | $206.8B | 5.55% | Share |
| 2 | Carlyle Group Inc. | 3,496,808 | $58.0B | 427.34% | Share |
| 3 | Invesco Ltd. | 3,147,908 | $52.2B | 8.01% | Share |
| 4 | Ensign Peak Advisors, Inc | 2,352,020 | $39.0B | 68.89% | Share |
| 5 | MILLENNIUM MANAGEMENT LLC | 2,082,180 | $34.0B | 14.30% | Share |
| 6 | NEA Management Company, LLC | 1,960,169 | $32.5B | 1.66% | Share |
| 7 | 683 Capital Management, LLC | 1,785,000 | $29.6B | 1.29% | Share |
| 8 | Catalys Pacific, LLC | 1,429,014 | $23.7B | 7.63% | Share |
| 9 | WASATCH ADVISORS LP | 1,331,669 | $22.1B | 131.27% | Share |
| 10 | Catalio Capital Management, LP | 698,996 | $11.6B | 2.05% | Share |
| 11 | Divisadero Street Capital Management, LP | 662,312 | $11.0B | 0.51% | Share |
| 12 | MOORE CAPITAL MANAGEMENT, LP | 600,000 | $10.0B | 143.28% | Share |
| 13 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 549,171 | $9.0B | 1.04% | Share |
| 14 | SummitTX Capital, L.P. | 517,820 | $8.6B | 0.26% | Share |
| 15 | Caption Management, LLC | 486,300 | $8.1B | 55.32% | Call |
| 16 | Invesco Ltd. | 443,834 | $7.4B | 1.13% | Share |
| 17 | NEXT CENTURY GROWTH INVESTORS LLC | 393,774 | $6.5B | 0.45% | Share |
| 18 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 397,910 | $6.0B | 0.93% | Share |
| 19 | Simplify Asset Management Inc. | 321,935 | $5.3B | 87.18% | Share |
| 20 | GOLDMAN SACHS GROUP INC | 341,909 | $5.0B | 0.62% | Share |
| 21 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 317,600 | $5.0B | 0.58% | Call |
| 22 | NORTHERN TRUST CORP | 314,664 | $5.0B | 0.64% | Share |
| 23 | Invesco Ltd. | 290,528 | $4.8B | 0.74% | Share |
| 24 | JPMORGAN CHASE & CO | 263,925 | $4.0B | 0.25% | Share |
| 25 | CITADEL ADVISORS LLC | 290,036 | $4.0B | 0.60% | Share |
| 26 | BANK OF AMERICA CORP /DE/ | 246,427 | $4.0B | 0.29% | Share |
| 27 | UBS Group AG | 237,825 | $3.9B | 0.64% | Share |
| 28 | Avidity Partners Management LP | 206,076 | $3.4B | 0.99% | Share |
| 29 | Birchview Capital, LP | 195,000 | $3.2B | 1.89% | Share |
| 30 | CAXTON ASSOCIATES LLP | 181,968 | $3.0B | 58.74% | Share |
| 31 | AMERIPRISE FINANCIAL INC | 185,715 | $3.0B | 0.68% | Share |
| 32 | BALYASNY ASSET MANAGEMENT L.P. | 207,085 | $3.0B | 3.81% | Share |
| 33 | Woodline Partners LP | 187,291 | $3.0B | 11.62% | Share |
| 34 | GILDER GAGNON HOWE & CO LLC | 145,174 | $2.4B | 25.42% | Share |
| 35 | D. E. Shaw & Co., Inc. | 171,379 | $2.0B | 1.10% | Share |
| 36 | SIMPLEX TRADING, LLC | 172,300 | $2.0B | 1.13% | Call |
| 37 | Hennion & Walsh Asset Management, Inc. | 114,981 | $1.9B | 0.07% | Share |
| 38 | GROUP ONE TRADING LLC | 103,684 | $1.7B | 3.00% | Share |
| 39 | UBS Group AG | 64,185 | $1.1B | 0.17% | Share |
| 40 | DARK FOREST CAPITAL MANAGEMENT LP | 62,248 | $1.0B | 0.05% | Share |
| 41 | WELLINGTON MANAGEMENT GROUP LLP | 90,158 | $1.0B | 0.18% | Share |
| 42 | Nuveen, LLC | 101,905 | $1.0B | 0.26% | Share |
| 43 | Swiss National Bank | 84,000 | $1.0B | 0.60% | Share |
| 44 | D. E. Shaw & Co., Inc. | 89,689 | $1.0B | 0.55% | Share |
| 45 | BARCLAYS PLC | 84,834 | $1.0B | 0.24% | Share |
| 46 | CITADEL ADVISORS LLC | 69,300 | $1.0B | 0.15% | Call |
| 47 | Stratos Wealth Partners, LTD. | 50,300 | $834.0M | 9.43% | Share |
| 48 | Virtus Investment Advisers, LLC | 46,937 | $778.0M | 0.21% | Share |
| 49 | ADAR1 Capital Management, LLC | 42,900 | $711.0M | 0.05% | Share |
| 50 | Kera Capital Partners, Inc. | 24,255 | $331.0M | 0.04% | Share |
PHAT Institutional Ownership History
| Quarter | Holders | Total Value | Change |
|---|---|---|---|
| Q4 2025 | 172 | $643.3B | +59 |
| Q3 2025 | 113 | $504.3B | +13 |
| Q2 2025 | 100 | $350.4B | -37 |
| Q1 2025 | 137 | $317.9B | -4 |
| Q4 2024 | 141 | $508.8B | +31 |
| Q3 2024 | 110 | $5.4T | +18 |
| Q2 2024 | 92 | $3.4T | +3 |
| Q1 2024 | 89 | $633.4T | — |
Similar Stocks by Institutional Ownership
As of Q4 2025, 50 institutional investors hold PHAT (Phathom Pharmaceuticals, Inc.). The largest holder is Frazier Life Sciences Management, L.P. with $206.8B in shares. This quarter, 5 institutions opened new positions and 2 closed their positions.
Frequently Asked Questions
How many hedge funds own PHAT?
As of Q4 2025, 50 institutional investors report holding PHAT (Phathom Pharmaceuticals, Inc.) in their 13F filings.
Who is the largest institutional holder of PHAT?
The largest institutional holder of PHAT is Frazier Life Sciences Management, L.P. with $206.8B in shares.
Is institutional ownership of PHAT increasing or decreasing?
This quarter, 5 institutions opened new positions in PHAT and 2 closed their positions.